Joachim Ossig

Title: Joachim Ossig - Innovator in Pain Management

Introduction

Joachim Ossig is a notable inventor based in Stolberg, Germany. He has made significant contributions to the field of pain management, particularly in relation to patients with impaired hepatic and renal function. His innovative approach has led to the development of a unique treatment option that addresses a critical need in healthcare.

Latest Patents

Joachim Ossig holds a patent for Cebranopadol, which is designed for treating pain in subjects with impaired hepatic and/or renal function. The invention relates to Cebranopadol or a physiologically acceptable salt thereof for use in the treatment or prevention of pain and/or opioid drug dependence in such subjects. This patent highlights his commitment to improving patient outcomes in challenging medical conditions. He has 1 patent to his name.

Career Highlights

Throughout his career, Ossig has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Grünenthal GmbH and Park Therapeutics, Inc. His work in these organizations has allowed him to collaborate with other experts and contribute to groundbreaking research in pain management.

Collaborations

Some of his notable coworkers include Elke Kleideiter and Annette Christoph. Their collaborative efforts have further advanced the research and development of innovative treatments in the field.

Conclusion

Joachim Ossig's contributions to pain management through his patent for Cebranopadol demonstrate his dedication to addressing the needs of patients with specific health challenges. His work continues to influence the pharmaceutical landscape and improve the quality of life for many individuals.